IFPMA Policy on Provision of Clinical Trial Data (2018.01.15)
The IFPMA (International Federation of Pharmaceutical Manufacturers and Associations) Policy on the Provision of Clinical Trial Data was issued by IFPMA on January 15, 2018. The Japan Pharmaceutical Manufacturers Association (JPMA) and other IFPMA organizations and member companies will provide clinical trial data in accordance with this policy. The policy includes the following five commitments
-
Enhanced disclosure of trial data, including individual data, to researchers
-
Enhanced public access to clinical research information
-
Sharing clinical trial results with subjects
-
Clarifying procedures for the release of clinical trial data
-
Reaffirming our commitment to the publication of clinical trial results